facebook
eISSN: 2084-9893
ISSN: 0033-2526
Dermatology Review/Przegląd Dermatologiczny
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
4/2016
vol. 103
 
Share:
Share:
abstract:
Review paper

Pharmacological treatment of actinic keratosis

Ewa Zwierzyńska
,
Anna Zawistowska
,
Bogusława Pietrzak

Przegl Dermatol 2016, 103, 330–336
Online publish date: 2016/09/01
View full text Get citation
 
PlumX metrics:
Actinic keratosis (AK) is a disease characterized by hyperkeratotic lesions on skin damaged by ultraviolet. radiation. These lesions may progress to squamous cell or basal cell carcinoma. Currently pharmacotherapy and different surgical procedures are used in AK therapy. The most common treatment options are 5-fluorouracil, imiquimod, diclofenac, ingenol mebutate, and first and third generation retinoids (retinol, adapalene, tazarotene). Furthermore, research is being carried out in order to test new medications including nicotinamide, resiquimod, piroxicam, potassium dobesilate and oleogel based on a triterpene extract (betulin, betulinic acid). Recently, the preventive effect of acetylsalicylic acid and celecoxib has also been investigated.
keywords:

actinic keratosis, pharmacotherapy, clinical studies



Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.